menu search

Why are biophytis shares trading higher during premarket trading?

Biophytis SA BPTS has received approval from the ANVISA (Brazilian health authority) for its Expanded Access Program (EAP) to treat hospitalized pa...

February 3, 2022, 9:03 am

Hologic q1 fy22 sales decline 9% on lower covid-19 assay sales; issues upbeat fy22 outlook

Hologic Inc  HOLX reported Q1 FY22 sales of $1.47 billion, beating the consensus of $1.18 billion and the company's expectations of $1.1 billion - $...

February 3, 2022, 8:33 am

Hologic q1 fy22 sales decline 9% on lower covid-19 assay sales; issues upbeat fy22 outlook

Hologic Inc  HOLX reported Q1 FY22 sales of $1.47 billion, beating the consensus of $1.18 billion and the company's expectations of $1.1 billion - $...

February 3, 2022, 8:33 am

Hologic q1 fy22 sales decline 9% on lower covid-19 assay sales; issues upbeat fy22 outlook

Hologic Inc  HOLX reported Q1 FY22 sales of $1.47 billion, beating the consensus of $1.18 billion and the company's expectations of $1.1 billion - $...

February 3, 2022, 8:33 am

Duolingo to announce fourth quarter and full year 2021 results on thursday, march 3, 2022

PITTSBURGH, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Duolingo, Inc. (Nasdaq: DUOL), the world's leading mobile languag...

February 3, 2022, 8:03 am

Duolingo to announce fourth quarter and full year 2021 results on thursday, march 3, 2022

PITTSBURGH, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Duolingo, Inc. (Nasdaq: DUOL), the world's leading mobile languag...

February 3, 2022, 8:03 am

Duolingo to announce fourth quarter and full year 2021 results on thursday, march 3, 2022

PITTSBURGH, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Duolingo, Inc. (Nasdaq: DUOL), the world's leading mobile languag...

February 3, 2022, 8:03 am

Cardinal health's q4 earnings hit by inflationary impacts, supply chain constraints; lowers fy22 outlook

Cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street estimate of $1.23. Thousands of new traders ar...

February 3, 2022, 7:47 am

Cardinal health's q4 earnings hit by inflationary impacts, supply chain constraints; lowers fy22 outlook

Cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street estimate of $1.23. Thousands of new traders ar...

February 3, 2022, 7:47 am

Cardinal health's q4 earnings hit by inflationary impacts, supply chain constraints; lowers fy22 outlook

Cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street estimate of $1.23. Thousands of new traders ar...

February 3, 2022, 7:47 am

Align technology's q4 clear aligner revenues fall sequentially, margins compress

Align Technology Inc ALGN reported Q4 sales of $1.03 billion, up 1.5% sequentially and 23.6% Y/Y, surpassing the consensus of $1.02 billion. Thousan...

February 3, 2022, 7:42 am

Align technology's q4 clear aligner revenues fall sequentially, margins compress

Align Technology Inc ALGN reported Q4 sales of $1.03 billion, up 1.5% sequentially and 23.6% Y/Y, surpassing the consensus of $1.02 billion. Thousan...

February 3, 2022, 7:42 am

Align technology's q4 clear aligner revenues fall sequentially, margins compress

Align Technology Inc ALGN reported Q4 sales of $1.03 billion, up 1.5% sequentially and 23.6% Y/Y, surpassing the consensus of $1.02 billion. Thousan...

February 3, 2022, 7:42 am

Roche expects slower fy22 sales growth on lower demand for covid-19 tests

Roche Holdings AG's RHHBY FY21 sales increased 8% Y/Y (9% on a constant currency basis) to CHF 62.8 billion. Thousands of new traders ar...

February 3, 2022, 7:37 am

Roche expects slower fy22 sales growth on lower demand for covid-19 tests

Roche Holdings AG's RHHBY FY21 sales increased 8% Y/Y (9% on a constant currency basis) to CHF 62.8 billion. Thousands of new traders ar...

February 3, 2022, 7:37 am

Roche expects slower fy22 sales growth on lower demand for covid-19 tests

Roche Holdings AG's RHHBY FY21 sales increased 8% Y/Y (9% on a constant currency basis) to CHF 62.8 billion. Thousands of new traders ar...

February 3, 2022, 7:37 am

Merck clocked $950m sales in q4 from covid-19 treatment, issues fy22 sales

Merck & Co Inc's MRK Q4 sales reached $13.52 billion, +24% Y/Y, beating the consensus of $13.16 billion.  Thousands of new traders ar...

February 3, 2022, 7:33 am

Merck clocked $950m sales in q4 from covid-19 treatment, issues fy22 sales

Merck & Co Inc's MRK Q4 sales reached $13.52 billion, +24% Y/Y, beating the consensus of $13.16 billion.  Thousands of new traders ar...

February 3, 2022, 7:33 am

Merck clocked $950m sales in q4 from covid-19 treatment, issues fy22 sales

Merck & Co Inc's MRK Q4 sales reached $13.52 billion, +24% Y/Y, beating the consensus of $13.16 billion.  Thousands of new traders ar...

February 3, 2022, 7:33 am

Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand

McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. Thousands of new t...

February 3, 2022, 5:50 am


Search within

Pages Search Results: